BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Metropolis Healthcare Ltd. has completed the 100% acquisition of Hitech Diagnostics Labs for a cash consideration of Rs 6.4 billion (funded via internal accrual and debt of Rs 3 billion at 5% cost of capital), implying valuation of five times FY21 sales and 13 times Ebitda FY21.
The deal, earlier in January 2021 was at Rs 6.2 billion (Rs 5.1 billion cash, 0.5 million share issuance), implied seven times FY20 sales and 30 times FY20 Ebitda).
The acquisition strengthens Metropolis Healthcare’s leadership position in Chennai, particularly in the business-to-consumer segment.
The company also has presence in Bangalore and other regions of Tamil Nadu, Karnataka and Kerala with a network of 31 laboratories and 68 collection centers.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR